Abstract
Medical practices for influenza virus infection vary among countries. In Japan, treatment with anti-influenza drugs is recommended for patients diagnosed with influenza. This health claims database study provides quantitative information aimed at describing the actual medical practices, including diagnostic testing and medication use, for managing influenza in Japan. Most patients diagnosed with influenza underwent diagnostic tests and were prescribed anti-influenza drugs. Meanwhile, the majority of patients prescribed anti-influenza drugs had undergone diagnostic testing. However, an increase in the percentage of anti-influenza prescriptions without diagnostic testing was observed during the 2019-2020 influenza season, which may be associated with the COVID-19 pandemic.
Keywords: COVID-19; antiviral agents; diagnosis; diagnostic tests; healthcare administrative claims; influenza.
【저자키워드】 COVID-19, Diagnosis, diagnostic tests, Antiviral agents, influenza., healthcare administrative claims, 【초록키워드】 Treatment, Antiviral, Influenza, COVID-19 pandemic, diagnostic test, Infection, diagnostic, Influenza virus, database, Health, diagnostic tests, healthcare, Antiviral agents, Patient, diagnostic testing, Japan, virus infection, medication, information, Quantitative, Most patients, anti-influenza drug, anti-influenza drugs, diagnosed, Most patient, provide, majority, increase in, 【제목키워드】 Health, treatment of influenza,